glp-1 announcement pricing is changing. Here’s what it means for you., ✅ Cash-pay drops to $299–$449, ✅ Medicare will cover obesity treatment, ✅ Oral versions coming at ~$149, #GLP1 #weightloss #ozempic #zepbound New legislation would lower cost

Description

Seniors cant get these drugs because Medicare is barred by law from covering them for obesity

It follows that the use of incretinomimetics activating the GLP-1R pathway may be an interesting lead for treating OA

Additionally, GLP-1 agonists slow gastric emptying, which contributes to prolonged fullness after meals

For comorbid metabolic diseases, such as diabetes and obesity, the use of GLP-1RAs generally does not increase cancer risk and may offer certain benefits

If you are on semaglutide and competing at an elite level, the responsible approach is to consult your national anti-doping organization directly and stay current on the Prohibited List status